STAMBP and Alzheimer disease: The aim of this study is to assess the effects of MCR agonist NDP-α-MSH in two transgenic mouse models of AD, 5XFAD and 3xTg mice, that markedly differ as regards the relationship between cognitive alterations and neuropathology.